Is INSP undervalued or overvalued?
As of 2025-03-24, the Intrinsic Value of Inspire Medical Systems Inc (INSP) is 75.83 USD. This INSP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 164.92 USD, the upside of Inspire Medical Systems Inc is -54.00%. This means that INSP is overvalued by 54.00%.
The range of the Intrinsic Value is 48.28 - 222.43 USD
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 48.28 - 222.43 | 75.83 | -54.0% |
DCF (Growth 10y) | 128.61 - 640.59 | 209.76 | 27.2% |
DCF (EBITDA 5y) | 79.60 - 118.21 | 87.92 | -46.7% |
DCF (EBITDA 10y) | 151.04 - 235.24 | 171.57 | 4.0% |
Fair Value | 45.09 - 45.09 | 45.09 | -72.66% |
P/E | 104.10 - 151.30 | 126.89 | -23.1% |
EV/EBITDA | 28.91 - 74.75 | 43.67 | -73.5% |
EPV | (9.09) - (12.76) | (10.92) | -106.6% |
DDM - Stable | 17.34 - 73.58 | 45.46 | -72.4% |
DDM - Multi | 53.73 - 183.69 | 83.93 | -49.1% |
Market Cap (mil) | 4,893.18 |
Beta | -0.25 |
Outstanding shares (mil) | 29.67 |
Enterprise Value (mil) | 4,743.03 |
Market risk premium | 4.60% |
Cost of Equity | 8.74% |
Cost of Debt | 4.48% |
WACC | 6.56% |